Precision Biosystems is a biotechnology startup based in Massachusetts that specializes in providing innovative instrument solutions for laboratory automation, with a focus on improving the quality of western blots. The company has developed the BlotCycler, an automated western blot processor that utilizes patented fluid distribution technology to fully automate the steps involved in the process, including shaking, blocking, hybridization, washing, and recycling of primary antibody. Furthermore, Precision Biosystems serves as the US distributor of the Qsep100 fluorescence DNA-CE microcapillary electrophoresis system, which offers superior resolution, sensitivity, and precise nucleic acid quantification for DNA and RNA molecules. The system's pen-shaped gel-electrophoresis cartridge is capable of conducting 200 tests at a rapid rate of 2-7 minutes per sample, with intuitive software and novel reagent packaging enhancing overall operational efficiency and consumables tracking. Founded in 2007, Precision Biosystems operates at the intersection of the biotechnology and healthcare industries. Although specific headquarters and recent investment details are not currently available, the company's innovative product offerings and commitment to addressing the challenges of laboratory automation position it as an intriguing prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Precision Biosystems.